Xu S - Search Results

1

Identification of a Novel Immune-Related lncRNA CTD-2288O8.1 Regulating Cisplatin Resistance in Ovarian Cancer Based on Integrated Analysis.

Liu T, Shen J, He Q, Xu S. Liu T, et al. Among authors: xu s. Front Genet. 2022 Feb 14;13:814291. doi: 10.3389/fgene.2022.814291. eCollection 2022. Front Genet. 2022. PMID: 35237300 Free PMC article.

2

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.

Li S, Li Q, Lü J, Zhao Q, Li D, Shen L, Wang Z, Liu J, Xie D, Cho WC, Xu S, Yu Z. Li S, et al. Among authors: xu s. Front Genet. 2020 Jan 14;10:1278. doi: 10.3389/fgene.2019.01278. eCollection 2019. Front Genet. 2020. PMID: 32010177 Free PMC article.

3

Integrated Bioinformatical Analysis Identifies GIMAP4 as an Immune-Related Prognostic Biomarker Associated With Remodeling in Cervical Cancer Tumor Microenvironment.

Xu F, Shen J, Xu S. Xu F, et al. Among authors: xu s. Front Cell Dev Biol. 2021 Jan 21;9:637400. doi: 10.3389/fcell.2021.637400. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33553190 Free PMC article.

4

Multi-Omics Data Analyses Construct a Six Immune-Related Genes Prognostic Model for Cervical Cancer in Tumor Microenvironment.

Xu F, Shen J, Xu S. Xu F, et al. Among authors: xu s. Front Genet. 2021 May 24;12:663617. doi: 10.3389/fgene.2021.663617. eCollection 2021. Front Genet. 2021. PMID: 34108992 Free PMC article.

5

Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis.

Shen J, Liu T, Bei Q, Xu S. Shen J, et al. Among authors: xu s. Front Oncol. 2021 Jun 17;11:685065. doi: 10.3389/fonc.2021.685065. eCollection 2021. Front Oncol. 2021. PMID: 34222009 Free PMC article.

6

Identification of an Immune-Related Prognostic Gene CLEC5A Based on Immune Microenvironment and Risk Modeling of Ovarian Cancer.

Shen J, Liu T, Lv J, Xu S. Shen J, et al. Among authors: xu s. Front Cell Dev Biol. 2021 Oct 12;9:746932. doi: 10.3389/fcell.2021.746932. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34712666 Free PMC article.

7

Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.

Xu F, Liu T, Zhou Z, Zou C, Xu S. Xu F, et al. Among authors: xu s. Front Immunol. 2021 Oct 21;12:749369. doi: 10.3389/fimmu.2021.749369. eCollection 2021. Front Immunol. 2021. PMID: 34745121 Free PMC article.

8

Identification of a Ferroptosis-Related Prognostic Gene PTGS2 Based on Risk Modeling and Immune Microenvironment of Early-Stage Cervical Cancer.

Zou C, Xu F, Shen J, Xu S. Zou C, et al. Among authors: xu s, xu f. J Oncol. 2022 Apr 8;2022:3997562. doi: 10.1155/2022/3997562. eCollection 2022. J Oncol. 2022. PMID: 35432535 Free PMC article.

9

Comprehensive analyses identify RIPOR2 as a genomic instability-associated immune prognostic biomarker in cervical cancer.

Xu F, Zou C, Gao Y, Shen J, Liu T, He Q, Li S, Xu S. Xu F, et al. Among authors: xu s. Front Immunol. 2022 Aug 26;13:930488. doi: 10.3389/fimmu.2022.930488. eCollection 2022. Front Immunol. 2022. PMID: 36091054 Free PMC article.

10

Transplantation of the LRP1^high subpopulation of human umbilical cord-derived mesenchymal stem cells improves ovarian function in mice with premature ovarian failure and aged mice.

Shen J, Wu L, Shi X, Chen G, Liu T, Xu F, Xu X, Kou X, Zhao Y, Wang H, Wang C, Gao S, Xu S. Shen J, et al. Among authors: xu s, xu f, xu x. Stem Cell Res Ther. 2024 Mar 5;15(1):64. doi: 10.1186/s13287-024-03660-0. Stem Cell Res Ther. 2024. PMID: 38438896 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27,222 results

Search Page

Filters